Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 5/20 | 0.37 |
| ▸ | DRD2 | P14416 | 5/20 | 0.37 |
| ▸ | DRD1 | P21728 | 5/20 | 0.37 |
| ▸ | DRD4 | P21917 | 5/20 | 0.37 |
| ▸ | DRD5 | P21918 | 5/20 | 0.37 |
| ▸ | DRD3 | P35462 | 5/20 | 0.37 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317886 | 1.00 | ALDH1A1 (0.43) | ALDH1A1TDP1HTR1ADRD2DRD1 | |
| SCHEMBL1316572 | 1.00 | ALDH1A1 (0.43) | ALDH1A1TDP1HTR1ADRD2DRD1 | |
| SCHEMBL1320721 | 1.00 | ALDH1A1 (0.43) | ALDH1A1TDP1HTR1ADRD2DRD1 | |
| SCHEMBL9670184 | 0.84 | ALDH1A1 (0.50) | ALDH1A1TDP1 | |
| SCHEMBL9027367 | 0.84 | ALDH1A1 (0.50) | ALDH1A1TDP1 | |
| SCHEMBL11301728 | 0.73 | PLA2G2A (0.44) | — | |
| SCHEMBL9192175 | 0.72 | SPHK2 (0.45) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL11306972 | 0.72 | TLR2 (0.41) | ALDH1A1TDP1HTR1ADRD2DRD1 | |
| SCHEMBL11541103 | 0.72 | TLR2 (0.41) | ALDH1A1TDP1HTR1ADRD2DRD1 | |
| SCHEMBL12677784 | 0.71 | TAAR1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269652-A1 | GEMINI SURFACTANTS | ST. FRANCIS XAVIER UNIVERSITY (CA) | 2011-11-03 | — | — | US | disclosed |
| EP-2349978-A1 | GEMINI SURFACTANTS | St. Francis Xavier University (CA) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010048715-A1 | GEMINI SURFACTANTS | ST. FRANCIS XAVIER UNIVERSITY (CA) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269652-A1 | GEMINI SURFACTANTS | SGMS1, DEGS1, GMNN | ALDH1A1 2106/4885TDP1 2255/4885HTR1A 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.